Vaginal Moisturizers and Lubricants: Clinical Considerations for Tissue Integrity, Microbiome Stability, and Patient Outcomes

The vulva and vagina deserve the same self-care considerations we provide to the rest of our body – at any stage of life. Vaginal moisturizers and lubricants can help protect the genitourinary epithelium from dryness, irritation, and injury, and may decrease susceptibility to bacterial and yeast infections, urinary tract infections, and sexually transmitted infections.

Vaginal moisturizers and lubricants are commonly considered analogous; however, they are distinctly different products, each with unique properties that influence epithelial integrity, microbiome stability and infection risk. For clinicians treating genitourinary syndrome of menopause (GSM), vulvovaginal pain, recurrent infections, dyspareunia, or pelvic pain disorders, product selection is not trivial.  Composition matters.

Vaginal Moisturizers: Tissue Hydration and Daily Support

Think of a vaginal moisturizer like a nightly facial moisturizer. These products are designed for routine use to increase the fluid content of mucosal tissues and support an optimal vaginal pH. Vaginal moisturizers commonly contain hyaluronic acid or polycarbophil-based compounds that help release and retain water within the vaginal epithelium.

Adequate vulvovaginal hydration supports:

• Epithelial barrier function

• Lactobacillus-dominant microbiota

• Physiologic vaginal pH (3.8-4.5)

• Reduced susceptibility to microtrauma

When vaginal tissue is less hydrated, pH may increase and become more alkaline. In hypoestrogenic states such as GSM, declining glycogen levels and reduced epithelial thickness also contribute to elevated vaginal pH.  An elevated vaginal pH can foster pathogenic bacterial growth, leading to vaginitis, vaginosis or urinary tract infections. As tissue hydration improves, vaginal pH tends to return toward an optimal physiologic range.

Vaginal moisturizers may be used up to 7 days per week as part of a self-care routine to support vulvar and vaginal health. While they can improve symptoms of GSM and support epithelial tissue health, they are not a substitute for vaginal hormone therapy. However, they may be used in conjunction with vaginal estrogen products or synthetic DHEA if indicated.

Vaginal Lubricants: Tissue Protection During Sexual Activity

Vaginal lubricants are intended for use during sexual activity to provide greater protection to vulvar and vaginal tissue than vaginal moisturizers. The vaginal epithelium is susceptible to microabrasions during penetration, regardless of perceived natural lubrication levels. These microabrasions can provoke or exacerbate symptoms associated with pelvic pain disorders such as vulvodynia or dyspareunia. They may also increase susceptibility to sexually transmitted infections.

Lubricants provide viscosity that reduces friction and microabrasions while relieving dryness during sexual activity. Although lubricants may reduce the risk of sexually transmitted infections by minimizing tissue trauma, they are not a substitute for condoms.

Lubricants may be silicone-based, water-based, hybrid (silicone + water) or oil-based. For optimal friction reduction and tissue protection, silicone-based lubricants are often preferred, particularly in patients with vulvar pain syndromes.

Types of Lubricants and Clinical Implications

Silicone-based

Pros

• best at reducing friction

• longest lasting lubricant

• preservative free

• anhydrous (no osmolality)

• safe with condoms

Cons

• not compatible with silicone dilators or toys

Water-based

Pros

• compatible with silicone, rubber, or plastic toys

• safe with condoms

Cons

• minimal to moderate friction reduction

• may require frequent reapplication

• requires scrutiny for pH, osmolality and additives

Hybrid (Silicone and Water)

Pros

• moderate friction reduction

• generally compatible with silicone dilators or toys

• safe with condoms

Cons

• requires scrutiny for pH, osmolality and additives

Oil-based

Pros

• longer lasting when compared to water-based lubricants

Cons

• Inconsistent data regarding epithelial cytotoxicity of plant-based oils, including coconut oil

• May irritate vulvar and vaginal tissues

• Petroleum oils associated with bacterial infections

• Baby oil associated with yeast infections

• Not compatible with latex condoms, silicone or rubber

Osmolality + Epithelial Integrity

Osmolality is a measurement used for water-based vaginal moisturizers and lubricants that reflects a product’s osmotic activity. Silicone and oil-based lubricants are typically anhydrous and therefore do not have an osmolality value.

Hyperosmolar products (>300 mOsm/kg) create an osmotic gradient that draws water out of epithelial cells, potentially leading to:

• Cellular dehydration

• Increased epithelial permeability

• Greater infection susceptibility

  
  

Hyperosmolar products have been associated with increased mucosal irritation, tissue damage and significant cytotoxic effects on vaginal epithelium.

Ideally, vaginal moisturizers and lubricants should be iso-osmolar (~300mOsm/kg) or slightly hypo-osmolar (< 300mOsm/kg).

WHO Recommendations and Market Reality

The World Health Organization recommends that personal lubricants have a pH ranging from 3.8 to 4.5 and an osmolality less than 380 mOsm/kg to minimize any risk of epithelial damage or cytotoxicity. Unfortunately, many commercially available products exceed these physiologic targets for both pH and osmolality.

Fertility Considerations

If fertility is the goal, sperm physiology must be considered.

For patients trying to conceive:

• Ideal lubricant osmolality: 270-280 mOsm/kg

• Sperm viability favors pH 7.2-8.5

  
  

Most standard lubricants negatively affect sperm motility unless specifically designed for fertility support.

Harmful Additives and Cytotoxicity

Many commercially available vaginal moisturizers or lubricants contain additives and preservatives intended to alter viscosity and extend shelf life. These ingredients may adversely affect the products pH, osmolality, and cytotoxicity.

Ingredients associated with epithelial and microbiome disruption include:

• Glycols (glycerine, glycerol, polypropylene glycol and polyethylene glycol-8)

• Parabens

• Chlorhexidine

• Nonoxynol-9

• Dyes, fragrances, warming agents, numbing agents, and flavoring

  
  

Products containing unnecessary additives and/or preservatives should be avoided whenever possible, particularly in individuals prone to urogenital infections, vulvar pain or GSM.

Clinical Takeaways

1. Vaginal moisturizers and lubricants serve different but equally important roles in achieving optimal vulvovaginal health.

2. Product osmolality and pH significantly impact epithelial integrity.

3. Hyperosmolar products may impair barrier function and increase infection risk.

4. Silicone-based lubricants provide superior vulvovaginal friction protection.

5. Product selection should be individualized based on hormonal status, symptom presentation, fertility goals, and tissue vulnerability.

Beyond Symptom Management

The health of the vulvovaginal epithelium is a meaningful treatment variable that can influence recovery outcomes. Recurrent infections, persistent dyspareunia, vulvar irritation, and symptom flares may be perpetuated by personal product choices that disrupt the vaginal ecosystem.

Product counseling is not ancillary education – it is a clinical intervention.

When we understand the physiologic implications of osmolality, pH, additive load, and friction reduction, we move beyond generic recommendations toward precision-based pelvic care.

In pelvic health practice, tissue environment matters.  As clinicians, we are uniquely positioned to assess tissue vulnerability and guide evidence-informed product selection.  Product counseling is not a peripheral conversation – it is precision care.  Thoughtful guidance regarding moisturizers and lubricants is one more way we elevate outcomes through intentional, evidence-informed practice.

How To Choose

Choose products that:

• Match the intended purpose – daily hydration vs. sexual activity

• Have a pH and osmolality within a normal physiologic range (when applicable)

• Free from unnecessary additives

  
  

We’ve included a curated list of products meeting safety criteria in a downloadable reference guide.

Vaginal Moisturizers and Lubricants Clinician Resource.pdf

Download PDF • 82KB

The Bottom Line

Vaginal moisturizers and lubricants serve distinct – but complementary – roles in vulvovaginal health.

Moisturizers support daily tissue hydration and microbiome stability.

Lubricants reduce friction and protect epithelial integrity during sexual activity.

When selected intentionally, both contribute to tissue resilience, symptom reduction, and long-term vulvovaginal health.

Thoughtful tissue care isn’t optional – it’s foundational to pelvic health practice.

References

1.    Pennycuff JF. The Osmolality of Sex-the Science of Vaginal Moisturizers and Lubricants. J Minim Invasive Gynecol. 2026;33(1):94-99.

2.    Vanderschee R, Kostov S. Approach to lubricant use for sexual activity. Can Fam Physician. 2025;71(7-8):e158-e166.

3.    Kagan R, Kellogg-Spadt S, Parish SJ. Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause. Drugs Aging. 2019;36(10):897-908.

4.    Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?. Climacteric. 2016;19(2):151-161.

5.    Wilkinson EM, Łaniewski P, Herbst-Kralovetz MM, Brotman RM. Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function. J Infect Dis. 2019;220(12):2009-2018.

6.    Dezzutti CS, Brown ER, Moncla B, et al. Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLoS One. 2012;7(11):e48328.

7.    Ayehunie S, Wang YY, Landry T, Bogojevic S, Cone RA. Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model. Toxicol Rep. 2017;5:134-140. Published 2017 Dec 16.

8.    Mackenzie SC, Gellatly SA. Vaginal lubricants in the couple trying-to-conceive: Assessing healthcare professional recommendations and effect on in vitro sperm function. PLoS One. 2019;14(5):e0209950.